Search research articles
Contact Us
Filters
Showing results (281-290 of 528) with videos related to
Page
of 53
Sort By:
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
|
July 20, 2017
Empowering survivors after colorectal and lung cancer treatment: Pilot study of a Self-Management Survivorship Care Planning intervention
Anne Reb, Nora Ruel, Marwan Fakih, et al.
Oncogene
|
February 22, 2002
Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells
Martin Sattler, Yuri B Pride, Laura R Quinnan, et al.
Oncotarget
|
May 8, 2018
Exosomal miRNAs species in the blood of small cell and non-small cell lung cancer patients
Valeriy Poroyko, Tamara Mirzapoiazova, Arin Nam, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
August 23, 2023
Phase II Trial of Lung Chemoembolization
F Edward Boas, Ravi Salgia, Thomas Waddington, et al.
Kidney Cancer (Clifton, Va.)
|
August 9, 2021
Twitter as a Tool to Spread Communication Regarding Genitourinary Cancers During the COVID-19 Pandemic
Sabrina Salgia, Nicholas Salgia, Sweta Prajapati, et al.
Clinical Lung Cancer
|
October 11, 2020
The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United States
Taylor R Cushman, Bernard Jones, David Akhavan, et al.
The Journal of Biological Chemistry
|
December 6, 2012
Critical role of S1PR1 and integrin β4 in HGF/c-Met-mediated increases in vascular integrity
Yulia Ephstein, Patrick A Singleton, Weiguo Chen, et al.
JCO Oncology Practice
|
July 9, 2020
Evaluation of Omics-Based Strategies for the Management of Advanced Lung Cancer
Ravi Salgia, Isa Mambetsariev, Rebecca Pharaon, et al.
Chest
|
April 20, 2021
Usefulness of Circulating Tumor DNA in Identifying Somatic Mutations and Tracking Tumor Evolution in Patients With Non-small Cell Lung Cancer
Moom R Roosan, Isa Mambetsariev, Rebecca Pharaon, et al.
Clinical Lung Cancer
|
November 22, 2011
Targeted and cytotoxic therapy in coordinated sequence (TACTICS): erlotinib, bevacizumab, and standard chemotherapy for non-small-cell lung cancer, a phase II trial
Ezra E W Cohen, Janakiraman Subramanian, Feng Gao, et al.
Page
of 53
Search research articles
Search
Showing results (281-290 of 528) with videos related to
Sort By:
Page
of 53
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
|
July 20, 2017
Empowering survivors after colorectal and lung cancer treatment: Pilot study of a Self-Management Survivorship Care Planning intervention
Anne Reb, Nora Ruel, Marwan Fakih, et al.
Oncogene
|
February 22, 2002
Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells
Martin Sattler, Yuri B Pride, Laura R Quinnan, et al.
Oncotarget
|
May 8, 2018
Exosomal miRNAs species in the blood of small cell and non-small cell lung cancer patients
Valeriy Poroyko, Tamara Mirzapoiazova, Arin Nam, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
August 23, 2023
Phase II Trial of Lung Chemoembolization
F Edward Boas, Ravi Salgia, Thomas Waddington, et al.
Kidney Cancer (Clifton, Va.)
|
August 9, 2021
Twitter as a Tool to Spread Communication Regarding Genitourinary Cancers During the COVID-19 Pandemic
Sabrina Salgia, Nicholas Salgia, Sweta Prajapati, et al.
Clinical Lung Cancer
|
October 11, 2020
The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United States
Taylor R Cushman, Bernard Jones, David Akhavan, et al.
The Journal of Biological Chemistry
|
December 6, 2012
Critical role of S1PR1 and integrin β4 in HGF/c-Met-mediated increases in vascular integrity
Yulia Ephstein, Patrick A Singleton, Weiguo Chen, et al.
JCO Oncology Practice
|
July 9, 2020
Evaluation of Omics-Based Strategies for the Management of Advanced Lung Cancer
Ravi Salgia, Isa Mambetsariev, Rebecca Pharaon, et al.
Chest
|
April 20, 2021
Usefulness of Circulating Tumor DNA in Identifying Somatic Mutations and Tracking Tumor Evolution in Patients With Non-small Cell Lung Cancer
Moom R Roosan, Isa Mambetsariev, Rebecca Pharaon, et al.
Clinical Lung Cancer
|
November 22, 2011
Targeted and cytotoxic therapy in coordinated sequence (TACTICS): erlotinib, bevacizumab, and standard chemotherapy for non-small-cell lung cancer, a phase II trial
Ezra E W Cohen, Janakiraman Subramanian, Feng Gao, et al.
Page
of 53